Redox regulation of the coagulation cascade

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1398-1404

  Görlach, Agnes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

BLOOD CLOTTING; CANCER RISK; CARDIOVASCULAR DISEASE; CYTOTOXICITY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HEMOSTASIS; HUMAN; METABOLIC DISORDER; MOLECULAR BIOLOGY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; FIBRINOLYSIS; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXYGEN; REACTIVE OXYGEN SPECIES; THROMBOSIS;

EID: 24144479451     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1398     Document Type: Short Survey

References (61)

1. Amer J and Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 92: 1052-1059, 2004.
2. Andrews RK and Berndt MC. Platelet physiology and thrombosis. Thromb Res 114: 447-453, 2004.
3. Anitua E, Andia I, Ardanza B, Nurden P, and Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91: 4-15, 2004.
4. BelAiba RS, Djordjevic T, Bonello S, Flugel D, Hess J, Kietzmann T, and Gorlach A. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol Chem 385: 249-257, 2004.
5. Bilgen D, Sonmez H, Ekmekci H, Ulutin T, Ozturk Z, Kokoglu E, Bayram C, Soner A, and Domanic N. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease. Clin Biochem 38: 92-96, 2005.
6. Binder BR, Christ G, Gruber F, Grubic N, Hufnagl P, Krebs M, Mihaly J, and Prager GW. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17: 56-61, 2002.
7. Chakrabarti S, Glutton P, Varghese S, Cox D, Mascelli MA, and Freedman JE. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release. Thromb Res 113: 225-233, 2004.
8. Chlopicki S, Olszanecki R, Janiszewski M, Laurindo FR, Panz T, and Miedzobrodzki J. Functional role of NADPH oxidase in activation of platelets. Antioxid Redox Signal 6: 691-698, 2004.
9. Chou DS, Hsiao G, Shen MY, Fong TH, Lin CH, Chen TF, and Sheu JR. Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study. Lipids 39: 433-440, 2004.
10. Chuang KP, Huang YF, Hsu YL, Liu HS, Chen HC, and Shieh CC. Ligation of lymphocyte function-associated antigen-1 on monocytes decreases very late antigen-4-mediated adhesion through a reactive oxygen species-dependent pathway. Blood 104: 4046-4053, 2004.
11. Clutton P, Miermont A, and Freedman JE. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 24: 187-192, 2004.
12. Coleman LG Jr, Polanowska-Grabowska RK, Marcinkiewicz M, and Gear AR. LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22). Blood 104: 380-389, 2004.
13. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Ndengele M, and Salvemini D. Superoxide-related signaling cascade mediates nuclear factor-κB activation in acute inflammation. Antioxid Redox Signal 6: 699-704, 2004.
14. Dahlback B. Blood coagulation. Lancet 355: 1627-1632, 2000.
15. Davi G, Neri M, Falco A, Festi D, Taraborelli T, Ciabattoni G, Basili S, Cuccurullo F, and Patrono C. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 25: 246-251, 2005.
16. Dimova EY, Samoylenko A, and Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal 6: 777-791, 2004.
17. Djordjevic T, Hess J, Herkert O, Gorlach A, and BelAiba RS. Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-κB pathway. Antioxid Redox Signal 6: 713-720, 2004.
18. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J, and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 519-525, 2005.
19. Djordjevic T, Pogrebniak A, BelAiba RS, Bonello S, Wotzlaw C, Acker H, Hess J, and Gorlach A. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 38: 616-630, 2005.
20. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
21. Essex DW. The role of thiols and disulfides in platelet function. Antioxid Redox Signal 6: 736-746, 2004.
22. Essex DW, Li M, Feinman RD, and Miller A. Platelet surface glutathione reductase-like activity. Blood 104: 1383-1385, 2004.
23. Ferroni P, Basili S, Falco A, and Davi G. Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal 6: 747-756, 2004.
24. Ferroni P, Basili S, Falco A, and Davi G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2: 1282-1291, 2004.
25. Franke K, Curth K, Lenart J, Knochenhauer D, and Kietzmann T. Enhanced plasminogen activator inhibitor-1 expression in transgenic mice with hepatocyte-specific overexpression of superoxide dismutase or glutathione peroxidase. Antioxid Redox Signal 6: 721-728, 2004.
26. Fukao H, Ijiri Y, Miura M, Hashimoto M, Yamashita T, Fukunaga C, Oiwa K, Kawai Y, Suwa M, and Yamamoto J. Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Blood Coagul Fibrinolysis 15: 441-446, 2004.
27. Germano G, Sanguigni V, Pignatelli P, Caccese D, Lenti L, Ragazzo M, Lauro R, and Violi F. Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens 22: 1151-1156, 2004.
28. Gorlach A. Redox control of blood coagulation. Antioxid Redox Signal 6: 687-690, 2004.
29. Gorlach A, Brandes RP, Bassus S, Kronemann N, Kirchmaier CM, Busse R, and Schini-Kerth VB. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J 14: 1518-1528, 2000.
30. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, and Busse R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89: 47-54, 2001.
31. Gorlach A, Kietzmann T, and Hess J. Redox signaling through NADPH oxidases: involvement in vascular proliferation and coagulation. Ann NY Acad Sci 973: 505-507, 2002.
32. Gorlach A, Berchner-Pfannschmidt U, Wotzlaw C, Cool RH, Fandrey J, Acker H, Jungermann K, and Kietzmann T. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb Haemost 89: 926-935, 2003.
33. Gregg D, de Carvalho DD, and Kovacic H. Integrins and coagulation: a role for ROS/redox signaling? Antioxid Redox Signal 6: 757-764, 2004.
34. Herkert O, Djordjevic T, BelAiba RS, and Gorlach A. Insights into the redox control of blood coagulation: role of vascular NADPH oxidase-derived reactive oxygen species in the thrombogenic cycle. Antioxid Redox Signal 6: 765-776, 2004.
35. Ishikawa M, Stokes KY, Zhang JH, Nanda A, and Granger DN. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res 94: 239-244, 2004.
36. Jordan PA, Stevens JM, Hubbard GP, Barrett NE, Sage T, Authi KS, and Gibbins JM. A role for the thiol isomerase protein ERP5 in platelet function. Blood 105: 1500-1507, 2005.
37. Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, and Takahashi K. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol 188: 180-188, 1999.
38. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis 57: S28-S29, 2004.
39. Lindenblatt N, Bordel R, Schareck W, Menger MD, and Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol 24: 601-606, 2004.
40. Liu Y, Pelekanakis K, and Woolkalis MJ. Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: regulation through c-Fos and c-Jun. J Biol Chem 279: 36142-36147, 2004.
41. Michiels C. Endothelial cell functions. J Cell Physiol 196: 430-443, 2003.
42. Nardi M, Feinmark SJ, Hu L, Li Z, and Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 113: 973-980, 2004.
43. Norata GD, Banfi C, Pirillo A, Tremoli E, Hamsten A, Catapano AL, and Eriksson R Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization. Br J Haematol 127: 97-104, 2004.
44. Ohkura N, Hiraishi S, Itabe H, Hamuro T, Kamikubo Y, Takano T, Matsuda J, and Horie S. Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. Antioxid Redox Signal 6: 705-712, 2004.
45. Olas B and Wachowicz B. Resveratrol reduces oxidative stress induced by platinum compounds in blood platelets. Gen Physiol Biophys 23: 315-326, 2004.
46. Olas B, Nowak P, and Wachowicz B. Resveratrol protects against peroxynitrite-induced thiol oxidation in blood platelets. Cell Mol Biol Lett 9: 577-587, 2004.
47. Peng L, Mundada L, Stomel JM, Liu JJ, Sun J, Yet SF, and Fay WP. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid Redox Signal 6: 729-735, 2004.
48. 2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 67: 491-502, 2004.
49. Robinson JM, Seguchi H, and Badwey JA. Active oxygen and nitrogen species in biology: from cytocidal agents to signaling intermediates. Histochem Cell Biol 122: 273-275, 2004.
50. Root P, Sliskovic I, and Mutus B. Platelet cell-surface protein disulphide-isomerase mediated 5-nitrosoglutathione consumption. Biochem J 382: 575-580, 2004.
51. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M, Sorge R, and Violi F. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 45: 35-42, 2005.
52. Spronk HM, Govers-Riemslag JW, and ten Gate H. The blood coagulation system as a molecular machine. Bioessays 25: 1220-1228, 2003.
53. Tam LS, Li EK, Leung VY, Griffith JF, Benzie IF, Lim PL, Whitney B, Lee VW, Lee KK, Thomas GN, and Tomlinson B. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol 32: 275-282, 2005.
54. Terasaka N, Hiroshima A, Ariga A, Honzumi S, Koieyama T, Inaba T, and Fujiwara T. Liver X receptor agonists inhibit tissue factor expression in macrophages. FEBS J 272: 1546-1556, 2005.
55. Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, and Maru Y. Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J Biol Chem 279: 4075-4083, 2004.
56. Vitseva O, Flockhart DA, Jin Y, Varghese S, and Freedman JE. The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates. J Pharmacol Exp Ther 312: 1144-1150, 2005.
57. Vulin AI and Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 279: 25172-25178, 2004.
58. Wagenaar GT, ter Horst SA, van Gastelen MA, Leijser LM, Mauad T, van der Velden PA, de Heer E, Hiemstra PS, Poorthuis BJ, and Walther FJ. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med 16: 782-801, 2004.
59. Wang JS. Strenuous, acute exercise suppresses polymorphonuclear leukocyte respiratory burst under adherence to surface-adherent platelets in men. Thromb Haemost 92: 1076-1085, 2004.
60. Wassmann S, Wassmann K, and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44: 381-386, 2004.
61. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, and Hirata Y. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145: 3331-3337, 2004.